DE69811382D1 - Carbapenemderivate und herstellungsverfahren dafür - Google Patents

Carbapenemderivate und herstellungsverfahren dafür

Info

Publication number
DE69811382D1
DE69811382D1 DE69811382T DE69811382T DE69811382D1 DE 69811382 D1 DE69811382 D1 DE 69811382D1 DE 69811382 T DE69811382 T DE 69811382T DE 69811382 T DE69811382 T DE 69811382T DE 69811382 D1 DE69811382 D1 DE 69811382D1
Authority
DE
Germany
Prior art keywords
derivatives
carbapen
production method
method therefor
carbapenem derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811382T
Other languages
English (en)
Other versions
DE69811382T2 (de
Inventor
Sang Woo Park
Dong Jin Kim
Kye Jung Shin
Yong Koo Kagn
Yong Zu Kim
Yong Ho Chung
Hong Woo Lee
Jae Doo Huh
Sang Joo Lee
Il Hong Suh
Bong Suk Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Il Hwa Co Ltd
Korea Institute of Science and Technology KIST
Original Assignee
Il Hwa Co Ltd
Korea Institute of Science and Technology KIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Hwa Co Ltd, Korea Institute of Science and Technology KIST filed Critical Il Hwa Co Ltd
Publication of DE69811382D1 publication Critical patent/DE69811382D1/de
Application granted granted Critical
Publication of DE69811382T2 publication Critical patent/DE69811382T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/04Preparation by forming the ring or condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69811382T 1997-09-13 1998-08-21 Carbapenemderivate und herstellungsverfahren dafür Expired - Fee Related DE69811382T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970047460 1997-09-13
PCT/KR1998/000255 WO1999014218A1 (en) 1997-09-13 1998-08-21 Carbapenem derivatives and a preparation method thereof

Publications (2)

Publication Number Publication Date
DE69811382D1 true DE69811382D1 (de) 2003-03-20
DE69811382T2 DE69811382T2 (de) 2003-10-23

Family

ID=19521343

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811382T Expired - Fee Related DE69811382T2 (de) 1997-09-13 1998-08-21 Carbapenemderivate und herstellungsverfahren dafür

Country Status (8)

Country Link
US (1) US6436921B1 (de)
EP (1) EP1023294B1 (de)
JP (1) JP3403173B2 (de)
KR (1) KR100327758B1 (de)
AT (1) ATE232533T1 (de)
CA (1) CA2303446C (de)
DE (1) DE69811382T2 (de)
WO (1) WO1999014218A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649756B2 (en) 2000-07-13 2003-11-18 Wyeth, Five Giralda Farms Process improvement in the preparation of (4r, 5s, 6s)-3-[[(2r,3r)-2-[[[(s)-2-amino-3-methyl-1-oxobutyl]amino]methyl]tetrahydro-3-furanyl]thio]-6-[(r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
PT1926732E (pt) 2005-09-05 2013-12-27 Ranbaxy Lab Ltd Processo para a preparação de compostos de carbapenem
BRPI0616563A2 (pt) * 2005-09-15 2012-12-25 Orchid Chemicals & Pharm Ltd processo melhorado para a preparaÇço de antibiàtico betalactÂmico
JP5406181B2 (ja) * 2007-06-28 2014-02-05 ケービーピー・バイオサイエンシズ・カンパニー・リミテッド 新規カルバペネム誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
FI96863C (fi) 1990-02-23 1996-09-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi

Also Published As

Publication number Publication date
KR19990029501A (ko) 1999-04-26
KR100327758B1 (ko) 2002-09-09
CA2303446C (en) 2004-10-26
EP1023294A1 (de) 2000-08-02
EP1023294B1 (de) 2003-02-12
WO1999014218A1 (en) 1999-03-25
JP3403173B2 (ja) 2003-05-06
DE69811382T2 (de) 2003-10-23
CA2303446A1 (en) 1999-03-25
US6436921B1 (en) 2002-08-20
JP2001516759A (ja) 2001-10-02
ATE232533T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
IL123293A0 (en) Piperidine derivatives their preparation and use
BR0208365A (pt) Derivados de 2-amino-propanol
ATE418547T1 (de) Zwischenprodukte zur herstellung von anti- thrombotischen 4h-cyclopenta-1,3-dioxol-derivaten
DE69817802D1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
BRPI9914221B8 (pt) derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
NO932870L (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
AU2000265939A1 (en) Novel pseudoerythromycin derivatives
HUP0301076A2 (hu) Linezolid II kristályforma és előállítása
DE69900794T2 (de) Herstellung von halbsandwich substituierten katalysator-vorläufern
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
MX9708696A (es) Cefalosporinas antibacterianas.
YU30603A (sh) Derivati premošćenog piperazina
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
DE69811382D1 (de) Carbapenemderivate und herstellungsverfahren dafür
DE69908614D1 (de) Herstellung von n-substituierten-hydroxycycloalkylamin-derivaten
DE69500327D1 (de) Verfahren zur Herstellung von azithromycin Dihydrochloriden
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
ATE419238T1 (de) Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz
DE69028285T2 (de) Cephalosporinderivate, ihre Herstellung und Anwendungen
ATE332892T1 (de) Zwischenverbindung für die herstellung von carvedilol
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
DE68901024D1 (de) Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
ES2134971T3 (es) Derivado de acido octahidro-2-naftaleno-carboxilico, su produccion y uso.
BR9910370A (pt) Compostos de cefalosporina, processo para preparar compostos de cefalosporina, e, composições antimicrobianas

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee